Nevro Corp. buy Royal Bank of Canada
Start price
17.08.23
/
50%
€17.60
Target price
17.08.24
€30.29
Performance (%)
-44.03%
Price
02.05.24
€9.85
Summary
This prediction is currently active. Massive losses of -44.03% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 17.08.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Nevro Corp. | -8.796% | -8.796% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Nevro Corp. diskutieren
Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $33.00 price target on the stock.
Ratings data for NVRO provided by MarketBeat